ChemoCentryx Financials

$9 M

Revenue Q3, 2017

$460.3 M

Mkt cap, 16-Feb-2018
Net income (Q3, 2017)(6.6 M)
EBIT (Q3, 2017)(6.9 M)
Cash, 30-Sep-201718 M

Market Value

Revenue/Financials

Income Statement

Annual

USDFY, 2016

Revenue

11.9 m

R&D expense

37.9 m

General and administrative expense

14.7 m

Operating expense total

52.7 m

EBIT

(40.7 m)

EBIT margin, %

(341%)

Interest expense

24 k

Interest income

757 k

Net Income

(40 m)

    Quarterly

    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

    Revenue

    2.8 m4.3 m8.2 m9 m

    R&D expense

    9 m7.5 m8.4 m8.6 m7.9 m11.2 m9.1 m8.4 m10 m

    General and administrative expense

    3.4 m3.5 m3.7 m3.6 m3.8 m4.1 m3.9 m3.2 m4.6 m

    Operating expense total

    12.4 m11.1 m12.1 m12.2 m11.7 m15.3 m12.9 m11.6 m14.5 m15.9 m

    EBIT

    (12.4 m)(11.1 m)(12.1 m)(12.2 m)(11.7 m)(15.3 m)(10.1 m)(7.3 m)(6.3 m)(6.9 m)

    EBIT margin, %

    (363%)(172%)(77%)(77%)

    Interest expense

    6 k4 k11 k6 k4 k

    Interest income

    129 k116 k103 k100 k95 k86 k161 k259 k317 k350 k

    Net Income

    (12.3 m)(10.9 m)(12 m)(12.1 m)(11.6 m)(15.2 m)(10 m)(7.1 m)(6 m)(6.6 m)

      Balance Sheet

      Annual

      USDFY, 2013FY, 2014FY, 2015FY, 2016

      Cash

      10.3 m16.1 m12.8 m12 m

      Accounts Receivable

      30.2 m

      Inventories

      596 k972 k757 k722 k

      Current Assets

      134.3 m74.3 m72 m148.7 m

      PP&E

      1.4 m1.2 m949 k905 k

      Total Assets

      152.4 m117 m78.2 m155.9 m

      Accounts Payable

      909 k748 k675 k671 k

      Current Liabilities

      6.9 m8.2 m5.5 m38.3 m

      Total Liabilities

      106 m

      Additional Paid-in Capital

      318.1 m328.4 m339.6 m357 m

      Retained Earnings

      (172.9 m)(219.8 m)(267.1 m)(307.1 m)

      Total Equity

      145.3 m108.6 m72.5 m49.9 m

      Financial Leverage

      1 x1.1 x1.1 x3.1 x

        Quarterly

        USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

        Cash

        13.1 m20.9 m25.4 m11.6 m14.6 m13.4 m21.9 m13.9 m19 m18 m

        Accounts Receivable

        175 k120 k30.2 m530 k

        Inventories

        1.3 m

        Current Assets

        100.8 m86.1 m76.1 m71.4 m74.2 m65.2 m127 m122.7 m119.9 m122.4 m

        PP&E

        1.2 m1.2 m1.2 m1.1 m1 m925 k858 k778 k984 k

        Total Assets

        135.5 m126.8 m107.3 m96.3 m87.2 m67.4 m142.3 m133.7 m152.4 m127.9 m

        Accounts Payable

        690 k1 m809 k1 m615 k1.3 m513 k840 k819 k1.4 m

        Current Liabilities

        7.9 m8.1 m7.7 m5.2 m5.5 m7.4 m23 m26.2 m42.5 m44.4 m

        Total Liabilities

        90.7 m

        Additional Paid-in Capital

        324 m326.1 m331.2 m334.7 m336.9 m342.1 m351.7 m353.7 m359.4 m366.2 m

        Retained Earnings

        (196.7 m)(207.6 m)(231.8 m)(243.9 m)(255.5 m)(282.3 m)(292.3 m)(299.4 m)(313.1 m)(328.9 m)

        Total Equity

        127.4 m118.5 m99.4 m90.9 m81.5 m59.8 m59.5 m54.4 m46.3 m37.3 m

        Financial Leverage

        1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x2.4 x2.5 x3.3 x3.4 x

          Cash Flow

          Annual

          USDFY, 2013FY, 2014FY, 2015FY, 2016

          Net Income

          (38.7 m)(46.9 m)(47.3 m)(40 m)

          Depreciation and Amortization

          576 k543 k477 k348 k

          Accounts Receivable

          (30.2 m)

          Accounts Payable

          159 k(161 k)(73 k)(4 k)

          Cash From Operating Activities

          (33.3 m)(34.3 m)(39.3 m)39.1 m

          Cash From Investing Activities

          (31.7 m)38.3 m33.9 m(48.8 m)

          Cash From Financing Activities

          66.8 m1.8 m2.2 m8.8 m

          Interest Paid

          26 k137 k137 k137 k

            Quarterly

            USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

            Net Income

            (12.3 m)(10.9 m)(12 m)(12.1 m)(11.6 m)(15.2 m)(10 m)(7.1 m)(6 m)(6.6 m)

            Accounts Receivable

            175 k120 k30.2 m530 k

            Inventories

            1.3 m

            Accounts Payable

            690 k1 m809 k1 m615 k1.3 m513 k840 k819 k1.4 m

              Ratios

              USDY, 2017

              Revenue/Employee

              145.6 k

              Financial Leverage

              3.4 x